Evidence map›Paper›PMID 9223286›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America1997

Activation of the orphan receptor RIP14 by retinoids.

A M Zavacki, J M Lehmann, W Seol, T M Willson, S A Kliewer, D D Moore

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 1997. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
4.2field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 87 citations in OpenAlex.

  1. Molecular Basis of Bile Acid-FXR-FGF15/19 Signaling Axis.International journal of molecular sciences · 2022
    Review
  2. Transcriptional Control ofInternational journal of molecular sciences · 2022
    Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Identification of a human nuclear receptor defines a new signaling pathway for CYP3A induction.Proceedings of the National Academy of Sciences of the United States of America · 1998
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

A M ZavackiDepartment of Molecular Biology, Massachusetts General Hospital, Boston, MA 02114, USA.
J M Lehmann
W Seol
T M Willson
S A Kliewer
D D Moore
Research Triangle Park Foundation · USMassachusetts General Hospital · US

Funding

NIDDK NIH HHS F32 DK09641
6 · The paper itself

Abstract

Retinoids are crucial regulators of a wide variety of processes in both developing and adult animals. These effects are thought to be mediated by the retinoic acid (RA) receptors and the retinoid X receptors (RXRs). We have identified an additional retinoid-activated receptor that is neither a retinoic acid receptors nor an RXR. RXR-interacting protein 14 (RIP14), a recently described orphan member of the nuclear receptor superfamily, can be activated by either all-trans-RA (tRA) or the synthetic retinoid TTNPB [[E]-4-[2-(5, 6, 7, 8-tetrahydro-5, 5, 8, 8-tetramethyl-2-naphthalenyl)propen-1-yl]benzoic acid].RIP14 binds to DNA as a heterodimer with RXR. In the presence of either tRA or TTNPB, the addition of 9-cis-RA or the RXR-specific agonist LG1069 [4-[1-(3, 5, 5, 8, 8-pentamethyl-5, 6, 7, 8-tertrahydro-2-naphthyl)ethenyl]benzoic acid] results in additional activation. Mutations of the ligand-dependent transcriptional activation functions indicate that TTNPB activates the RIP14 component of the RIP14-RXR heterodimer, that 9-cis-RA and LG1069 activate RXR, and that tRA activates via both RIP14 and RXR. Despite the very effective activation of RIP14 by tRA or TTNPB, relatively high concentrations of these compounds are required, and no evidence for direct binding of either compound was obtained using several approaches. These results suggest that RIP14 is the receptor for an as-yet-unidentified retinoid metabolite.

Indexed as

Receptors, Cytoplasmic and NuclearTrans-ActivatorsAnimalsCarrier ProteinsCell LineDNA-Binding ProteinsKruppel-Like Transcription FactorsMiceMutagenesisRatsReceptor, Farnesoid X-ActivatedReceptors, Retinoic AcidRetinoidsRetinoid X ReceptorsSequence DeletionTranscription FactorsCarrier ProteinsDNA-Binding ProteinsKlf2 protein, mouseKruppel-Like Transcription FactorsReceptor, Farnesoid X-ActivatedReceptors, Cytoplasmic and NuclearReceptors, Retinoic AcidRetinoidsRetinoid X ReceptorsTrans-ActivatorsTranscription Factors

Identifiers

PMID9223286
PMCPMC21528
OpenAlexW1982609634

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.